IADVL
Indexed with PubMed and Science Citation Index (E) 
 
Users online: 3107 
     Home | Feedback | Login 
About Current Issue Archive Ahead of print Search Instructions Online Submission Subscribe What's New Contact  
  Navigate here 
  Search
 
   Next article
   Previous article 
   Table of Contents
  
 Resource links
   Similar in PUBMED
    Search Pubmed for
    Search in Google Scholar for
   [PDF Not available] *
   Citation Manager
   Access Statistics
   Reader Comments
   Email Alert *
   Add to My List *
* Registration required (free)  

 
  In this article
   To the Editor,
   References

 Article Access Statistics
    Viewed2616    
    Printed42    
    Emailed0    
    PDF Downloaded0    
    Comments [Add]    

Recommend this journal

 


 
LETTER TO EDITOR
Year : 1995  |  Volume : 61  |  Issue : 3  |  Page : 180-181

Febrile herxheimer reaction




Correspondence Address:
Neena Khanna


Login to access the Email id

Source of Support: None, Conflict of Interest: None


PMID: 20952946

Rights and PermissionsRights and Permissions



How to cite this article:
Khanna N, Pandhi R K. Febrile herxheimer reaction. Indian J Dermatol Venereol Leprol 1995;61:180-1

How to cite this URL:
Khanna N, Pandhi R K. Febrile herxheimer reaction. Indian J Dermatol Venereol Leprol [serial online] 1995 [cited 2019 Oct 21];61:180-1. Available from: http://www.ijdvl.com/text.asp?1995/61/3/180/4199



  To the Editor, Top


Febrile Herxheimer reaction (FHR) is a transient exacerbation of mucocutaneous lesions along with fever, occurring when patients of early syphilis are treated with treponemicidal drugs. To the best of our knowledge, there are no studies on the incidence and symptomatology of FHR in patients of early syphilis.

Fifty-eight patients of previously untreated syphilis (19 with primary and 39 with secondary) were treated with 2.4 mega units of benzathine penicillin injected intramuscularly after ruling out sensitivity to pencillin. The diagnosis was confirmed in all cases by DGI and/or serology. The axillary temperature was recorded immediately before the injection and thereafter at hourly intervals for 48 hours. A rise in the axillary temperature to at least 37.4C was considered as a positive reaction. The patients were questioned regarding any change in preexisting skin lesions and/or appearance of any new lesions. They were also asked if any constitutional symptoms had developed during this period.

Fifteen (78.9%) patients with primary syphilis developed FHR. Eleven (73.3%) of these patients were seropositive, while 4 (26.7%) were seronegative. All the 4(100%) patients who did not develop FHR were seronegative. The mean of maximum axillary temperature recorded was 37.9C (0.77) and this was recorded on an average 7.5 (4.2) hours after the injection. Though the number of patients was small, there was a suggestion that patients with seronegative primary syphilis are less likely to develop FHR than those with seropositive primary lesions.

Four (26.7%) patients also developed swelling and tenderness of the primary ulcer and 2 patients developed a temporary phimosis. Two (13.4%) patients developed a transient maculopapular rash, and one developed generalised lymphadenopathy.

Thirty-five (89.7%) patients with secondary syphilis developed FHR. Of the 4 (10.3%) patients who did not 3(75%) had nodular syphilis, a manifestation of late secondary syphilis. The mean of maximum axillary temperature recorded was 38.0C(0.6) and this was recorded on an average 6.5(0.28) hours after treatment was initiated. In all but one patient, the febrile reaction subsided within 48 hours.

In 2 of the 5 patients who had evidence of concomitant chancre, there was oedema of the ulcer. Interestingly one patient developed oedema and ulceration at the site of healed primary ulcer. Eight (22.9%) patients developed new mucocutaneous lesions or noticed exacerbation of pre-existing lesions. Symptoms like headache, arthralgia, giddiness and sore throat developed in 18(51.4%) patients.

In an earlier study, Farmer[2] observed that FHR occurred with equal frequency in seronegative and seropositive primary syphilis. However, the present study corroborates the findings of Putkonen et al[3] who found that FHR occurred more frequently in seropositive than seronegative syphilis.

The reported frequency of FHR in secondary syphilis varies from 45% to 76%.[4]In the present study 89.7% of patients of secondary syphilis developed FHR. Of the 4 patients who did not develop the febrile reaction, 75% had nodular syphilis, a manifestation of late secondary syphilis. This suggests that FHR may be less common in late secondary syphilis.

 
  References Top

1.Morton RS. The Treponematosis. In: Textbook of dermatology (Champion RH, Burton JL, Ebling FJG, eds). 5th edn. Oxford: Blackwell Scientific Publications, 1992:1112-1113.  Back to cited text no. 1    
2.Farmer TW. The Herxheimer reaction in early syphilis treated with crystalline penicillin G. JAMA 1948:138:480-5.  Back to cited text no. 2    
3.Putkonen T, Salo OP, Mustakallio K. Febrile Herxheimer reaction in different phases of primary and secondary syphilis. Br J Ven Dis 1966;42:181-4.  Back to cited text no. 3    
4.Aronson IK, Soltani K. The enigma of pathogenesis of the Jarisch-Herxheimer reaction. Br J Ven Dis 1976;52:313-5.  Back to cited text no. 4  [PUBMED]  




 

Top
Print this article  Email this article
Previous article Next article

    

Online since 15th March '04
Published by Wolters Kluwer - Medknow